Literature DB >> 33357311

[Analysis of Clinical Characteristics of 35 Cases 
of Pulmonary Sclerosing Pneumocytoma].

Xiaojing Liu1, Zhihao Huang1, Jianyong Zhang1.   

Abstract

BACKGROUND: Pulmonary sclerosing pneumocytoma (PSP) is rare benign lung tumor which usually develops in middle-aged women without typical clinical and imaging findings. PSP consists of two basic cell types (surface cubic epithelial cells and round mesenchymal cells) and four histological types (hemorrhagic, sclerotic, solid and papillary). It grows slowly, but it can metastasize to distant organs. The pathology before surgery is easily misdiagnosed. This study aims to improve clinicians' understanding of PSP by discussing the clinical characteristics of the disease.
METHODS: This represents a retrospective study of thirty-five patients diagnosed with pulmonary sclerosing pneumocytoma by pathological examination from January 2011 to December 2019.
RESULTS: A total of 35 patients in this study, 12 cases were male and 23 cases were female, the average age is 51 years old. 7 cases were discovered accidentally by physical examination or routine chest computed tomography (CT), and 28 cases were found due to symptoms such as cough, sputum, hemoptysis and chest pain. The imaging changes is mainly featured with isolated or clear circular or round-like single nodule and lump in the lungs. In this group, 12 cases underwent percutaneous lung biopsy, only 7 cases were diagnosed with PSP. A total of 28 patients underwent surgery, 24 cases underwent rapid frozen pathological biopsy, only 5 cases diagnosed with PSP. Postoperative pathological examination results shows that 1 case was diagnosed with keratotic squamous cell carcinoma with partial PSP, and the rest were diagnosed with PSP. The surgical and non-surgical patients were followed up for 1 to 8 years after discharge, and the overall recovery was good. The patients were no recurrence and metastasis on chest CT review.
CONCLUSIONS: PSP is a clinically rare benign lung tumor, which is more common in middle-aged women. The clinical manifestations and imaging features are lack of significance. Percutaneous lung puncture pathological examination and intraoperative rapid frozen pathological sections often leads to misdiagnosis. Final diagnosis relies on postoperative pathological work-up for most cases.

Entities:  

Keywords:  Benign tumor; Pulmonary sclerosing hemangioma; Pulmonary sclerosing pneumocytoma

Year:  2020        PMID: 33357311      PMCID: PMC7786227          DOI: 10.3779/j.issn.1009-3419.2020.103.19

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


  31 in total

1.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung.

Authors:  Seung-Hyun Jung; Min Sung Kim; Sung-Hak Lee; Hyun-Chun Park; Hyun Joo Choi; Leeso Maeng; Ki Ouk Min; Jeana Kim; Tae In Park; Ok Ran Shin; Tae-Jung Kim; Haidong Xu; Kyo Young Lee; Tae-Min Kim; Sang Yong Song; Charles Lee; Yeun-Jun Chung; Sug Hyung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

3.  Sclerosing Pneumocytoma of the Lungs Arising in a Child With PTEN Mutation.

Authors:  Youssef Nasr; Marcos Bettoli; Dina El Demellawy; Harman Sekhon; Joseph de Nanassy
Journal:  Pediatr Dev Pathol       Date:  2019-06-05

4.  A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis.

Authors:  I Tanaka; M Inoue; Y Matsui; S Oritsu; O Akiyama; T Takemura; M Fujiwara; T Kodama; Y Shimosato
Journal:  Jpn J Clin Oncol       Date:  1986-03       Impact factor: 3.019

5.  Pulmonary sclerosing hemangioma with a rare symptom: A case report and review of the literature.

Authors:  Le Zhou; Chuntang Sun; Yan Huang; Qiao Li; Huairong Tang; Youjuan Wang
Journal:  Mol Clin Oncol       Date:  2016-12-21

6.  Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report.

Authors:  Guanming Jiang; Min Zhang; Qinquan Tan; Shunhuan Lin; Yihong Zeng; Chun Liu; Rongrong Chen; Jianping Zhou
Journal:  Lung Cancer       Date:  2019-09-06       Impact factor: 5.705

Review 7.  Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.

Authors:  Sanja Dacic; Eizaburo Sasatomi; Patricia A Swalsky; Dong Won Kim; Sydney D Finkelstein; Samuel A Yousem
Journal:  Arch Pathol Lab Med       Date:  2004-08       Impact factor: 5.534

8.  Increased expression of matrix metalloproteinase 9 and tubulin-alpha in pulmonary sclerosing hemangioma.

Authors:  Su Jin Cho; Lian-Jin Jin; Bu-Yeo Kim; Su-In Cho; Woon Yong Jung; Joung-Ho Han; Seong-Yeon Ha; Han Kyeom Kim; Aeree Kim
Journal:  Oncol Rep       Date:  2007-11       Impact factor: 3.906

Review 9.  Sclerosing pneumocytoma mixed with a typical carcinoid tumor: A case report and review of literature.

Authors:  Zhao Wang; Mai-Qing Yang; Wen-Jing Huang; Di Zhang; Hong-Tao Xu
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Concomitance of pulmonary spindle cell carcinoma and sclerosing pneumocytoma in a woman: A case report.

Authors:  Xu LuLu; Shu Jian
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.